MedTrace Logo

TAP-Block in Abdominal Aortic Surgery

NCT03657979 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-09-05

No results posted yet for this study

Summary

The primary outcome of this study was the evaluation of the efficacy of TAP block on pain intensity following open abdominal aortic surgery.

Conditions

  • Aortic Aneurysm, Abdominal

Interventions

DRUG

Ropivacaine

TAP-block Ropivacaine 0.2% during 48 hours

DRUG

Placebo

TAP-block with placebo

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Principal Investigators

  • Claude GIRARD, Professor · Anesthesia unit

  • Eric STEINMETZ, Professor · Cardiovascular and thoracic surgery unit

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-05
Primary Completion
2012-08-29
Completion
2012-08-29

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03657979 on ClinicalTrials.gov